Show simple item record

Circulating interleukin-18 (IL-18) as a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.

dc.contributor.authorKARABULUT, Senem
dc.contributor.authorBilgin, Elif
dc.contributor.authorKarabulut, Mehmet
dc.contributor.authorTuna, Savas
dc.contributor.authorAlis, Halil
dc.contributor.authorTAŞ, Faruk
dc.contributor.authorGonenc, Murat
dc.contributor.authorDagoglu, Nergiz
dc.contributor.authorAfsar, Cigdem Usul
dc.date.accessioned2022-02-18T08:54:49Z
dc.date.available2022-02-18T08:54:49Z
dc.identifier.citationAfsar C. U. , Karabulut M., KARABULUT S., Tuna S., Alis H., Gonenc M., Dagoglu N., Bilgin E., TAŞ F., "Circulating interleukin-18 (IL-18) as a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.", Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34
dc.identifier.othervv_1032021
dc.identifier.otherav_06aeeb4a-0be1-46ee-b9c2-9dc76f7a7da6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/176103
dc.identifier.urihttps://doi.org/10.1200/jco.2016.34.15_suppl.e15678
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleCirculating interleukin-18 (IL-18) as a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume34
dc.contributor.firstauthorID3384229


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record